Загрузка...
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
BACKGROUND: Persistent patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. Prostaglandin synthetase inhibitors such as indomethacin promote PDA closure but also have potential side effects. The effect of the prophylactic use of indomethacin, where infants wh...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2010
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045285/ https://ncbi.nlm.nih.gov/pubmed/20614421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000174.pub2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|